107 
Viralytics - well positioned with a Phase II about to begin
Is Viralytics well positioned with a Phase II about to begin considering its rival coampnies with similar approaches yet different viruses have market caps between $150M to 200M with Phase II & Phase III candidates. Also does anyone have insight into Viralytics likely relase date of its current Phase I trials re head and neck & breast cance?
|
Terms & Rules
As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use
Comments